The University of Houston has received a $3.8 million award from the National Institutes of Health to launch a five-year study evaluating whether continuous glucose monitors (CGMs) can be an effective and accessible tool for preventing or delaying progression to Type 2 diabetes among underserved populations. With an estimated 115 million U.S. adults living with prediabetes, researchers and clinicians from UH Health, the University’s academic hea…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.